Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark becomes the First Pharmaceutical Company to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults’.
The above information is a part of company’s filings submitted to BSE.